Earnings Summary

Omega Healthcare Investors Inc.’s revenue jumped 14.05% since last year same period to $276.03Mn in the Q3 2024. On a quarterly growth basis, Omega Healthcare Investors Inc. has generated 8.1% jump in its revenue since last 3-months.

Omega Healthcare Investors Inc.’s net profit jumped 22.3% since last year same period to $111.76Mn in the Q3 2024. On a quarterly growth basis, Omega Healthcare Investors Inc. has generated -1.84% fall in its net profits since last 3-months.

Omega Healthcare Investors Inc.’s net profit margin jumped 7.24% since last year same period to 40.49% in the Q3 2024. On a quarterly growth basis, Omega Healthcare Investors Inc. has generated -9.2% fall in its net profit margins since last 3-months.

Omega Healthcare Investors Inc.’s price-to-earnings ratio after this Q3 2024 earnings stands at 29.32.

Omega Healthcare Investors Inc.’s earning per share (EPS) estimates for the current year stand at 0.32.

Omega Healthcare Investors Inc.’s earning per share (EPS) jumped 13.51% since last year same period to 0.42 in the Q3 2024. This indicates that the Omega Healthcare Investors Inc. has generated 13.51% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Omega Healthcare Investors Inc.’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Omega Healthcare Investors Inc.’s return on equity (ROE) stands at 0.09.

Omega Healthcare Investors Inc. declared 0.67 dividend per share during the earnings announcement for Q3 2024.